[FONT=Times]Le propecia est connu pour donner des troubles sexuels mais ceux ci ne sont en général pas prolongés car la demie vie du médicament est de 5,5 heures, cela veux dire qu'après 7 jours il reste environ 1,56% de la dose initiale - c'est à dire presque rien.
Nous sommes informés que certains patients se plaignent de troubles sexuels prolongés - au fait quel problème avez vous - diminution du désir sexuel, érections insuffisantes ? éjaculations inhabituelles ?
Au jour d'aujourd'hui, il n'a pas été possible de mettre en cause le finastéride dans la survenue de troubles sexuels prolongés car il faut savoir que les troubles sexuels ne sont pas rares dans la population générale qui ne prend pas ce médicament. Constater des troubles sexuels prolongés chez des patients qui ont pris le finastéride, n'est pas équivalent à indiquer la responsabilité de cette molécule dans la survenue des troubles sexuels. Dans les études initiales, les troubles sexuels étaient présents chez 3,8% des patients sous finastéride mais aussi chez 2,1% des patients prenant un placebo… lire ces [URL="http://www.bernsteinmedical.com/medical-treatment/medications/propecia-finasteride/"]informations sur le finastéride.[/URL]
Les patients comme vous ont été entendus et des audits sont en cours - comme auprès de la [URL="http://www.ishrs.org/articles/finasteride-announcement.htm"]société internationale de chirurgie capillaire[/URL][/FONT]
[FONT=Times]International Society of Hair Restoration Surgery Task Force on Finasteride Adverse Event Controversies [/FONT]
[FONT=Times]April 29, 2011[/FONT][FONT=Times][/FONT]
[FONT=Times]Since 1998, [URL="http://www.ishrs.org/nonsurgical/options-propecia.htm"]finasteride [/URL](Propecia®) has successfully helped millions of men with [URL="http://www.ishrs.org/hair-loss/hair-loss-male.htm"]androgenetic alopecia[/URL] with a relatively low side effect profile. Recently, several reports in the media and health-related literature have described a number of younger men with androgenetic alopecia who claim to have experienced persistent sexual side effects following the use and subsequent discontinuation of finasteride. The [URL="http://www.ishrs.org/"]International Society of Hair Restoration Surgery[/URL] (ISHRS) has established the Task Force on Finasteride Adverse Event Controversies to evaluate published data and to inform and update our ISHRS members regarding the use of this medication.[/FONT]
[FONT=Times]To date, there is no evidence-based data substantiating the link between finasteride and persistent sexual side effects in the numerous double blinded, placebo controlled studies using finasteride 1mg for hair loss. Reports of persistent sexual side effects have come from a variety of sources, with some internet sites attracting individuals claiming to have sexual and psychological issues related to finasteride. While continued difficulty having erections after discontinuing finasteride has been reported in post-marketing surveillance the incidence of this problem remains unknown. This rare side effect is included in Merck’s patient product information in the United States, and in Public Assessment Reports of the Medicines and Health Regulatory Agency of the United Kingdom and the Medical Products Agency of Sweden. [/FONT]
[FONT=Times]The persistence of sexual side effects appears to be a rare event, and it has yet to be determined whether these recent reports represent a true causal relationship, or if they are simply coincidental and related to other factors such as the high incidence of sexual dysfunction in the general population, and/or the placebo effect. Also, little data is available concerning the medical and psychological workup of these patients to exclude other potential causative factors. [/FONT]
[FONT=Times]At the present time, the mechanism of interaction between the brain, 5 alpha-reductase metabolism, and hormones on sexual dysfunction is speculative and poorly understood. Clearly, this is a complicated issue, which overlaps with other disciplines in medicine such as Endocrinology, Urology, and Psychiatry. More research is needed to assess the actual incidence of side effects, to determine if there is a true causal relationship for persistent side effects, and, if so, to identify who may be at risk. We hope to participate in a multidisciplinary forum to further evaluate this topic.[/FONT]
[FONT=Times]Millions of patients have benefitted from finasteride with no side effects at all, or minimal and reversible side effects. It is important for the medical community to verify anecdotal reports, and, if necessary, conduct further studies so that accurate information may be given to our patients to enable them to make informed choices regarding the use of this medication. [/FONT]
[FONT=Times]The ISHRS Task Force on Finasteride Adverse Event Controversies is in the process of gathering information and forming an interdisciplinary panel to address these issues and to keep our ISHRS members informed regarding post- marketing adverse events[/FONT]
L'information ou le conseil en ligne ne sont pas des consultations médicales et ne doivent exonérer ni le médecin ni le patient d'une véritable consultation avec une anamnèse et un examen clinique qui seuls peuvent permettre d'aboutir à un diagnostic et à une prescription.
Dr Philippe Abimelec, Dermatologue